ISMP has identified possible safety issues with Paxlovid, which was recently authorized for the treatment of COVID-19. Tablets need to be removed from the blister pack for patients with moderate renal impairment. For a copy of ISMP’s special alert with safe practice recommendations, visit: https://www.ismp.org/node/29033
MSOS News
Post date: 9 months 2 weeks ago
Surgery sites now have more time to participate in the ISMP Medication Safety Self Assessment for Perioperative Settings! The data submission deadline has been extended to February 11, 2022. Don’t miss this opportunity to evaluate your medication use systems, identify challenges, and document regulatory compliance. Visit www.ismp.org/node/18027 to access the assessment workbook.
Post date: 9 months 3 weeks ago
ISMP is receiving a steady stream of error reports on age-related mix-ups with the COVID vaccine. A National Alert (NAN) warning has been issued with safe practice recommendations: https://www.ismp.org/node/28619
Post date: 10 months 1 week ago
ISMP is receiving reports of confusion and errors with monoclonal antibody products used to treat COVID-19, due to unfamiliar co-packaging and labeling. Read this week’s ISMP newsletter featured article for safe practice recommendations: https://www.ismp.org/node/28457
Post date: 10 months 2 weeks ago
Sign up now for the next MSOS Member Briefing webinar scheduled to be held on Thursday, November 18, 2021 from 1:00-2:00 PM ET.
Register Now: https://ecri.zoom.us/webinar/register/WN_266jVUPfTeOaOXignK2AVA
Short medication safety-related presentations for this webinar will include:
• Human Factors Engineering of Heparin Nurse Managed Protocol
Mark Wolf Jr., PharmD
PGY2 Medication-Use Safety and Policy Pharmacy Resident
University of Kentucky HealthCare
• Medication Events Related to Cancelled Labs
Magdalena Mastalerz, PharmD
PGY2 Health-Systems Pharmacy Administration & Leadership Resident
University of Kentucky HealthCare